TODAY'S HEADLINES
Add us to your address book or trusted sender list to help ensure delivery.

For the latest news, features, columns, video and audio reports and more, visit our home page at www.medpagetoday.com

Cancer Diagnosis May Not Generate Healthy Living

HALIFAX, Nova Scotia -- Many cancer survivors don’t follow healthy lifestyles, according to epidemiologists here. full story

http://www.medpagetoday.com/HematologyOncology/OtherCancers/tb/9272

Survey Is ECG a Plus Before ADHD Therapy?

The American Heart Association has said it’s reasonable to do a baseline ECG before starting children on stimulant therapy for ADHD. Vote

OTHER MEDPAGE TODAY EXTRAS

Blogs

Campaign '08

Focus on Policy

Multimedia

Investigational Drug Slows Functional Decline in Early Alzheimer’s

OXFORD, England -- The investigational anti-amyloid drug tarenflurbil (Flurizan) significantly slowed declines in the overall ability to function among mild Alzheimer’s disease patients, researchers here said. full story

http://www.medpagetoday.com/Geriatrics/AlzheimersDisease/tb/9277

CWL: Pathogen Swapping at Daycare May Protect Against Leukemia

LONDON -- Daycare has been associated with a reduced risk of childhood acute lymphoblastic leukemia by giving the immune system an early workout, researchers said here. full story

http://www.medpagetoday.com/InfectiousDisease/GeneralInfectiousDisease/tb/9275

FDA Rejects Merck’s No-Flush Niacin
ROCKVILLE, Md. -- The FDA has informed drug maker Merck & Co., that it will not approve the company’s patient-friendly niacin compound. full story

http://www.medpagetoday.com/ProductAlert/Prescriptions/tb/9274

Gene Variants Linked to Osteoporosis and Bone Mineral Density

LONDON -- Identifications of genetic variants associated with the loss of bone mineral density and the risk of osteoporosis were reported independently today by two research groups. full story

http://www.medpagetoday.com/Endocrinology/Osteoporosis/tb/9271

Exercise Helps Cut Heart Disease Risk Regardless of Weight

BOSTON -- Overweight and obese women could lessen their risk of coronary heart disease with regular exercise, researchers found. full story

http://www.medpagetoday.com/Cardiology/CoronaryArteryDisease/tb/9273

Reasons Documented for Heart Failure Admissions

LOS ANGELES -- Almost two-thirds of the time, hospitalization for heart failure can be blamed on one or more identifiable precipitating factors, researchers here said. full story

http://www.medpagetoday.com/Cardiology/CHF/tb/9270

NSAID Improves Insulin Secretion in Obesity

GIRONA, Spain -- The aspirin-like agent triflusal may reverse early signs of diabetes among otherwise healthy obese patients, researchers found. full story

http://www.medpagetoday.com/Endocrinology/Diabetes/tb/9269

Thicker Blood Equals Better Recovery from Blood Loss in Animals

LA JOLLA, Calif. -- The effects of traumatic blood loss may be eased, paradoxically, by thickening the plasma that remains, researchers here are suggested. full story

http://www.medpagetoday.com/EmergencyMedicine/EmergencyMedicine/tb/9268

Glitazone Diabetes Drugs May Increase Fracture Risk

BASEL, Switzerland -- Taking glitazone drugs for diabetes has been significantly associated with low-trauma fractures, researchers here found a case-control study. full story

http://www.medpagetoday.com/Cardiology/Diabetes/tb/9267

Hormone May Be Guide to Biological Clock

UTRECHT, The Netherlands -- An easy-to-measure hormone may be a better predictor of menopause than chronological age, researchers here said. full story

http://www.medpagetoday.com/Endocrinology/Menopause/tb/9266

Low-Normal Thyroid Function Linked to Cardiac Death

TRONDHEIM, Norway -- Women with thyroid function at the low end of normal appear to be at significantly increased risk for death from coronary heart disease, researchers here said. full story

http://www.medpagetoday.com/Cardiology/CoronaryArteryDisease/tb/9259

CME SPOTLIGHT

Emerging Patient Challenges in COPD: Interactive Case Simulator
Designed for primary care clinicians. This case-based CME activity provides a virtual learning experience, allowing participants to order diagnostic tests, prescribe drugs, diagnose and develop new treatment strategies; simulating clinical practice.
Source: CASIVUS [more]

Targeted Cancer Therapy From Trial To Clinic
Join Drs. Balducci, Atkins, Cantley, and Herbst for an innovative and in-depth CME-certified Activity on how integration of targeted and conventional therapies for treating cancer is improving patient outcomes.
Source: The Physicians Academy For Clinical and Management Excellence [more]

Emerging Trends in the Treatment of Renal Cell Carcinoma
Drs. Michael B. Atkins, Bernard J. Escudier, and Gary R. Hudes lead this CME activity which examines current and evolving standards of care for the treatment of early stage and advanced renal cell carcinoma; best practices for optimal patient outcomes are also covered.
Source: The Physicians Academy For Clinical and Management Excellence [more]

Case Study: Targeted Adjuvant Therapy for HER2-Positive Breast Cancer
Free CME/CE/CPE case-based newsletter. Harold J. Burstein, MD, PhD, considers treatment options for a patient with HER2-positive invasive breast cancer and describes how patient age, medical history, and HER2 status can be used to predict prognosis and aid in selecting an appropriate targeted therapy.
Source: Projects In Knowledge [more]

Medical and Surgical Management of Aortic Valve Disease
Join Dr. Joseph E. Bavaria, MD and the team of University of Pennsylvania cardiology and surgery specialists in reviewing of all the important topics related to aortic valve conditions that a cardiovascular clinician faces on a daily basis.
Source: University of Pennsylvania School of Medicine [more]

Myeloma Landscape 2008: Highlights in Frontline Therapy, Transplantation, and Relapsed/Refractory Disease.
This activity reviews these trials as well as new developments in transplantation and relapsed/refractory therapies.
Source: Curatio CME Institute [more]

The Evolution and Role of Incretin-Based Therapeutics.
This activity reviews the pathogenesis of type 2 diabetes, the mechanisms by which incretin hormones affect glucose homeostasis, and the role of incretin-based therapeutics in the management of type 2 diabetes.
Source: SciMed New York [more]

Evolution in the Use of Boosted PIs as First-line Therapy: Factors to Consider
Drs Graeme Moyle and Sharon Walmsley review studies that compare efficacy, safety, and metabolic parameters of PIs in head-to-head trials along with emerging data on drug-drug interactions and insulin resistance.
Source: AdvancMed [more]

RESOURCES

Review safety, efficacy and PIs for Pfizer oncology medicines; search clinical trials, review pipeline, and more
Visit PfizerOncology.com to access the latest reprints, slides, and other resources, organized by tumor type; efficacy, safety, and dosing for Pfizer oncology drugs; current oncology news; clinical trials suitable for your patients; and more. Source: Pfizer [more]

Frequently painful. Potentially severe. Learn why your patients maybe be at risk.
Zoster: How Many of your patients are at risk? Source: Merck [more]

Find comprehensive, up-to-date information about clinical trials in oncology with TrialTrove™
Visit www.rocheexchange.com to access TrialTrove™, a real-time global oncology clinical trials database. For your convenience, each trial summary describes the study design, inclusion and exclusion criteria, and where the research is being conducted. Source: Roche [more]

Learn how Starlix® helps control mealtime glucose surges in patients with Type 2 Diabetes
View this e-learning for the latest information on Starlix and order valuable resources including samples and patient education materials. Source: Novartis [more]

View product information to discover more about sequential therapy in early breast cancer
Efficacy ? Safety ? Dosing ? Key reprints ? Materials and tools ? Easy-to-read prescribing information ? Patient educational materials Source: Pfizer [more]